Beyond The Printed Page
-
Food For Free – An Example Of How Life Science Cares Approaches Engagement
2/17/2020
Food For Free is an example for how Life Science Cares engages with its community of greater Boston.
-
Gaurav Shah — A Rare Disease Biopharma CEO Shares A Rare Experience
2/6/2020
Dr. Gaurav Shah, M.D., CEO of Rocket Pharmaceuticals, shares some of his rare experiences, such as what it is like to be nominated (as a musician) for a GRAMMY award, his company’s upcoming rare disease day, and more.
-
An Interview with Robert Hariri, M.D., Ph.D., CEO and founder of Celularity
1/28/2020
A video of Life Science Leader chief editor, Rob Wright, interviewing Robert (Bob) Hariri, M.D., Ph.D., CEO and founder of Celularity, at the 2019 CNS Summit.
-
Why Top Researchers And Physicians Enter The World Of Biopharma R&D
1/13/2020
David Chang, M.D., Ph.D., founder and CEO of Allogene Therapeutics, along with numerous other physicians have opted to become biopharmaceutical executives, but one doesn’t have to go to medical school to be driven to make a difference for patients.
-
Genmab's Commercial Engine Aspirations
12/16/2019
Jan G. J. van de Winkel, Ph.D., cofounder and CEO of Genmab, discusses the company’s aspirations to eventually commercialize its own products.
-
What Should Biopharma Employees Be Paying Close Attention To In 2020 & Beyond?
12/2/2019
Seven biopharmaceutical industry CEOs share their thoughts on trends, innovations, and what biopharma employees should be paying attention to in 2020 and beyond.
-
IPO Window, Recession, Trade War & More -- 5 Biopharma Finance Experts Share Their Perspectives For 2020
12/2/2019
Five biopharmaceutical industry finance experts share their perspectives for what the industry can expect in 2020 and beyond.
-
Tariff Wars, Politics, And Other Concerns Of 6 Biopharma CEOs For 2020 And Beyond
12/2/2019
Six biopharma CEOs talk tariff wars, politics, and other concerns for 2020 and beyond.
-
7 Biopharma Manufacturing Execs Detail What To Expect in 2020 -- And Beyond
12/2/2019
Seven biopharmaceutical executives share their perspectives on what to expect in biopharma manufacturing in 2020 and beyond.
-
What Makes A Biopharma Serial Entrepreneur Tick? Part 1
10/28/2019
Rob Wright explores what makes a serial entrepreneur tick (part 1) via Brad Margus, cofounder and CEO of Cerevance. Margus may have started out in the shrimping business, but he went on to found a disease specific 501c3 nonprofit, ultimately leading him to found three different biopharmaceutical companies.